Effects of high efficiency post-dilution on-line hemodiafiltration or conventional hemodialysis on residual renal function and left ventricular hypertrophy

International Urology and Nephrology

Volumn 45, Issue 5, 2013, Pages 1389-1396

  Schiffl, Helmut ^a,b   Lang, Susanne M ^c   Fischer, Rainald ^b  

^a KfH Nierenzentrum München Laim ^*  (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c SRH Wald Klinikum Gera   (Germany)

Author keywords

Conventional hemodialysis; Left ventricular hypertrophy; On line hemodiafiltration; Residual renal function

Indexed keywords

ANTIHYPERTENSIVE AGENT; LOOP DIURETIC AGENT; NEPHROTOXIC AGENT; PHOSPHATE BINDING AGENT; RECOMBINANT ERYTHROPOIETIN; TOXIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARDIOVASCULAR PARAMETERS; COHORT ANALYSIS; COMPARATIVE STUDY; DEMOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIAFILTRATION; HEMODIALYSIS; HIGH EFFICIENCY POST DILUTION ON LINE HEMODIAFILTRATION; HUMAN; HYPERTENSION; HYPOTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; LEFT VENTRICULAR MASS INDEX; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RESIDUAL RENAL FUNCTION;

AGED; ANTIHYPERTENSIVE AGENTS; C-REACTIVE PROTEIN; FEMALE; FOLLOW-UP STUDIES; HEMODIAFILTRATION; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; HYPOTENSION; INFLAMMATION; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 84887069852     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-012-0336-4     Document Type: Article

References (32)

1. Brener ZZ, Thijssen S, Kotanko P, Kuhlmann MK, Bergman M, Winchester JF, Levin NW (2011) The impact of residual renal function on hospitalization and mortality in incident hemodialysis patients. Blood Purif 31:243-251
2. Shafi T, Jaar BG, Plantinga LC, Fink NE, Sadler JH, Parekh RS, Powe NR, Coresh J (2010) Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the choices for healthy outcomes in caring for end-stage renal disease (CHOICE) study. Am J Kidney Dis 56:348-358
3. Shemin D, Bostom AG, Laliberty P, Dworkin LD (2001) Residual renal function and mortality risk in hemodialysis patients. Am J Kidney Dis 38:85-90
4. Vilar E, Wellsted D, Chandna SM, Greenwood RN, Farrington K (2009) Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis dose. Nephrol Dial Transplant 24:2502-2510
5. National Kidney Foundation (2006) KDOQI Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis 48:S2-S90
6. Lysaght MJ, Vonesh EF, Gotch F, Ibels L, Keen M, Lindholm B, Nolph KD, Pollock CA, Prowant B, Farrell PC (1991) The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans 37:598-604
7. Horinek A, Misra M (2004) Does residual renal function decline more rapidly in hemodialysis than in peritoneal dialysis? How good is the evidence? Adv Perit Dial 20:137-140
8. Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT (2002) Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 62:1046-1053
9. Schiffl H, Lang SM, Fischer R (2002) Ultrapure dialysis fluid slows loss of residual renal function in new dialysis patients. Nephrol Dial Transplant 17:1814-1818
10. Lang SM, Bergner A, Topfer M, Schiffl H (2001) Preservation of residual renal function in dialysis patients: effects of dialysis-technique-related factors. Perit Dial Int 21:52-57
11. Hartmann J, Fricke H, Schiffl H (1997) Biocompatible membranes preserve residual renal function in patients undergoing regular hemodialysis. Am J Kidney Dis 30:366-373
12. McKane W, Chandna SM, Tattersall JE, Greenwood RN, Farrington K (2002) Identical decline of residual renal function in high-flux biocompatible hemodialysis and CAPD. Kidney Int 61:256-265
13. Hyodo T, Koutoku N (2011) Preservation of residual renal function with HDF. Contrib Nephrol 168:204-212
14. Covic A, Goldsmith DJ, Georgescu G, Venning MC, Ackrill P (1996) Echocardiographic findings in long-term, long-hour hemodialysis patients. Clin Nephrol 45:104-110
15. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE (2000) Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease. J Am Soc Nephrol 11:912-916
16. Paoletti E, Specchia C, Di MG, Bellino D, Damasio B, Cassottana P, Cannella G (2004) The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey. Nephrol Dial Transplant 19:1829-1834
17. Haag-Weber M (2008) The impact of residual renal function on survival. Nephrol Dial Transplant 23:2123-2126
18. Canaud B (2008) Residual renal function: the delicate balance between benefits and risks. Nephrol Dial Transplant 23:1801-1805
19. Gunal AI, Kirciman E, Guler M, Yavuzkir M, Celiker H (2004) Should the preservation of residual renal function cost volume overload and its consequence left ventricular hypertrophy in new hemodialysis patients? Ren Fail 26:405-409
20. European Best Practice Guidelines on Haemodialysis.(Part 1) (2002) Measurement of renal function, when to refer and when to start dialysis. Nephrol Dial Transplant 17(suppl 7):7-15
21. Sahn DJ, DeMaria A, Kisslo J, Weyman A (1978) Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58:1072-1083
22. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450-458
23. Shin SK, Noh H, Kang SW, Seo BJ, Lee IH, Song HY, Choi KH, Ha SK, Lee HY, Han DS (1999) Risk factors influencing the decline of residual renal function in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 19:138-142
24. Vaslaki LR, Berta K, Major L, Weber V, Weber C, Wojke R, Passlick-Deetjen J, Falkenhagen D (2005) On-line hemodiafiltration does not induce inflammatory response in end-stage renal disease patients: results from a multicenter cross-over study. Artif Organs 29:406-412
25. Glassock RJ, Pecoits-Filho R, Barberato SH (2009) Left ventricular mass in chronic kidney disease and ESRD. Clin J Am Soc Nephrol 4(Suppl 1):S79-S91
26. Ardeleanu S, Panaghiu L, Prisada O, Sascau R, Voroneanu L, Hogas S, Mardare N, Covic A (2011) Regression of left ventricular hypertrophy in hemodialyzed patients is possible: a follow-up study. Int Urol Nephrol 43:1161-1169
27. Kong CH, Farrington K (2003) Determinants of left ventricular hypertrophy and its progression in high-flux haemodialysis. Blood Purif 21:163-169
28. Palmieri V, Tracy RP, Roman MJ, Liu JE, Best LG, Bella JN, Robbins DC, Howard BV, Devereux RB (2003) Relation of left ventricular hypertrophy to inflammation and albuminuria in adults with type 2 diabetes: the strong heart study. Diabetes Care 26:2764-2769
29. Masiha S, Sundstrom J, Lind L (2012) Inflammatory markers are associated with left ventricular hypertrophy and diastolic dysfunction in a population-based sample of elderly men and women. J Hum Hypertens doi: 10.1038/jhh.201.113
30. Ohtake T, Oka M, Ishioka K, Honda K, Mochida Y, Maesato K, Moriya H, Hidaka S, Kobayashi S (2012) Cardiovascular protective effects of on-line hemodiafiltration: comparison with conventional hemodialysis. Ther Apher Dial 16:181-188
31. Alvestrand A, Ledebo I, Hagerman I, Wingren K, Mattsson E, Qureshi AR, Gutierrez A (2011) Left ventricular hypertrophy in incident dialysis patients randomized to treatment with hemofiltration or hemodialysis: results from the ProFil study. Blood Purif 32:21-29
32. Schmid H, Schiffl H (2012) Hemodiafiltration and survival of end-stage renal disease patients: the long journey goes on. Int Urol Nephrol 44:1435-1440